The pharmaceutical industry is considered to be a well-funded industry, but it is also an extremely competitive industry. The following is a survey report of pharmaceutical companies I collected for your reference, hoping to help friends in need!
Pharmaceutical industry is considered to be an industry with sufficient funds, but it is also an industry with extremely fierce competition. Externally, under the promise of China's entry into WTO, multinational pharmaceutical companies, including the top 20 multinational pharmaceutical companies in the world, have set up offices in China. Internally, the problems of restructuring and GMP certification have kept pharmaceutical companies busy. How to occupy a dominant position in the environment of internal and external attack has become a crucial hurdle for pharmaceutical enterprises. Only by improving management and service means and reducing costs through information technology can successful pharmaceutical enterprises win? Famous doctor's prescription? .
Current situation of informatization in pharmaceutical industry
Pharmaceutical enterprises generally include drugs, medical devices, chemicals and glass instruments. As a typical continuous manufacturing pharmaceutical enterprise, pharmaceutical enterprises have their own unique industry characteristics because they produce special commodities such as drugs and chemical reagents: for example, there are many kinds of drugs; The code is not standardized, and the validity period must be strictly controlled; Strong dependence on patents (formulas); The sales range is wide, and the sales situation of each sales area and variety is not easy to grasp as a whole; There are many and complicated factors affecting drug pricing, and it is difficult to control the sales terminal resources (hospitals and pharmacies); Drugs are updated quickly, but the research and development cycle of new products is long.
In addition, the four-level wholesale system of pharmaceutical products circulation, which was closed for nearly 50 years, was completely broken with the separation of medicines, chain operation and GSP reaching the standard. Under the heavy market pressure, how to sell drugs has become the core of every enterprise. Therefore, mechanism innovation, optimizing process and strengthening management have become the highlights of major pharmaceutical companies. Facing the brand-new market competition environment, it is necessary to start a new marketing model. Therefore, there is an urgent need to fundamentally reform management means, and management must rely on a sound information system.
What software does medical informatization involve? From the perspective of drug circulation, there are several links at present. Firstly, the internal management of manufacturers, mainly involving ERP system; The process from manufacturer to wholesale enterprise, distribution enterprise and hospital involves logistics system, online trading system and CRM system. There is also his system in the hospital, which is the hospital information management system.
According to reports, at present, about 20% of large and medium-sized pharmaceutical enterprises have completed the implementation of ERP, mainly focusing on procurement, sales, warehousing, finance and other modules; About 50% pharmaceutical enterprises are promoting and implementing ERP, and they are mainly concentrated in the fields of supply chain, distribution and fund management. From the current implementation of ERP in some pharmaceutical enterprises, it can be seen that almost all enterprises start with marketing.
Six deficiencies of medical informatization
With the in-depth development of medical circulation system, medical and health system and medical security system reform, the comprehensive implementation of classified management of prescription drugs and over-the-counter drugs and the implementation of designated pharmacies, the informationization in the medical field has begun to develop greatly, but it shows great imbalance. For example, the informatization of hospitals has made great progress, while the informatization of pharmaceutical enterprises and pharmaceutical retail enterprises is far from that of hospitals. At present, there are still the following shortcomings in the informatization of the pharmaceutical industry.
First, the information management mechanism is outdated. To solve the problem of enterprise informatization mechanism, it is necessary to establish standardized information system management data.
Second, the distribution center and computer system are not perfect. Modern pharmaceutical enterprises have generally formed an ecological chain model integrating drug research and development, production and sales, including drug retailers and hospitals. Some pharmaceutical enterprises also have special pharmacy retail chain terminals, so chain is a very new topic for Chinese pharmaceutical enterprises, and the imperfect distribution model can not be well integrated with information systems.
The third is the ability to expand the scale regardless of the degree of informationization. Under the national policy of supporting the establishment of top pharmaceutical enterprises 100 and top 50 sales terminals, there has been blind expansion, but the management system has not kept up.
Fourth, there is a shortage of information professionals.
Fifth, chain enterprises lack an effective chain management system. Especially the lack of supply chain management system and distribution logistics system. Sixth, when choosing a system, pharmaceutical enterprises should pay attention to the surface rather than the core, to the product rather than the realization, and to the initial operation of the product rather than the maintenance and service.
Nine Demands of Medical Informatization
Yang, deputy general manager of Neusoft Golden Abacus Marketing, believes that enterprises need nine kinds of management software, and China pharmaceutical enterprises need logistics management most, which is the first step for China enterprises. Logistics management software can make enterprise decision makers very clear about the procurement cost, transportation cost, sales gross profit and turnover of raw materials, spare parts and finished products. Logistics management can also be extended to business management, which is the pharmacy chain of pharmacies.
The second step after the establishment of logistics management is production management, which must be carried out on the basis of solving logistics management.
The third is human resource management. After solving the problems of logistics management and production management, enterprises need to manage the participation time, implementation cost, personnel quality, skill demand and required training items of employees in production and circulation.
The fourth is product design management. When the enterprise reaches a certain scale, it is very necessary to manage the process of product from creativity to product research, product design, product setting and product technology by computer.
The fifth is financial cost accounting. Management accounting is what enterprises need most. Only when logistics cost management is clear and labor cost analysis is clear can financial cost accounting appear. Product design management software should also be implemented before financial cost accounting software, so that every input of the enterprise can be measured very accurately. Financial cost accounting not only needs to manage specific goods, production and personnel, but also needs to manage the related costs of enterprises such as market research, market development, capital cost and fixed assets management.
The sixth is the financial report. After China's entry into WTO, there is a great demand for financial reports, because the accounting systems in different countries are completely different, and the financial attributes of the same ticket may be completely different in different countries. There is such an enterprise in Hong Kong now, and it will cost millions of Hong Kong dollars to reissue vouchers in Hong Kong, because the situation in the Mainland simply does not meet the requirements of Hong Kong's financial system.
Seventh, financial report analysis. Through the financial report analysis software, business leaders have a deeper understanding of the business situation of the enterprise and the financial situation of customers, suppliers, partners and other units.
The eighth is enterprise decision analysis. Business leaders need to make decision-making analysis of business operations frequently, and the data of decision-making analysis must be timely and accurate, and the analysis methods also need to be constantly innovated.
The ninth is enterprise resource management software, that is, ERP, and then e-commerce construction is carried out to establish a perfect medical ecological chain information system, which is the last step in building the system.
Investigation Report of Pharmaceutical Enterprises (II) Shijiazhuang is an important production base of pharmaceutical industry approved by the State Council. At present, there are 58 pharmaceutical enterprises above designated size in the city, accounting for 80% of the total pharmaceutical industry in China, and it is the largest raw material medicine base in China. Shijiazhuang pharmaceutical industry has become the first dominant industry in the city, and its production scale, economic strength, fixed assets, foreign exchange earning through export and labor productivity of all employees rank first in the city.
The present situation of Shijiazhuang pharmaceutical chain enterprises;
According to the statistics of U.S. Food and Drug Administration in Shijiazhuang, there are 2 19 1 retail pharmacies in * *, including 179 chain pharmacies, including six districts under the jurisdiction of the city 178, and there are only 1 chain pharmacies outside the municipal area, and the chain rate of pharmacies in the city is only 8%. The whole city 179 chain stores are basically occupied by several local chain enterprises, among which 68 emerging pharmacies rank first, 53 Shenwei pharmacies, 4 1 family of Lerentang Group (excluding 9 pharmacies) and about1family of Shijiazhuang Yikang Pharmacy. The development speed of foreign chain enterprises in Shijiazhuang is not fast. At present, there are only 8 stores in Shijiazhuang. According to conservative estimates by insiders, the scale of Shijiazhuang pharmaceutical retail market is about 654.38+0 billion yuan. Although the number of single pharmacies is absolutely dominant in the whole market, chain pharmacies occupy the vast majority of the market share in terms of sales. In 2009, the sales of Lerentang Shijiazhuang Pharmaceutical Chain and Shijiazhuang Xinxing Pharmacy both reached 265.438+0 billion yuan, and Hebei Shenwei Pharmacy was 65.438+0.8 billion yuan, which divided up 60% of the market share, while the foreign-funded chain enterprise Renmin Pharmacy ranked fourth with sales of more than 60 million yuan.
By the end of 2003, there were 5 1 pharmaceutical manufacturing enterprises in Shijiazhuang with total assets of 29.23 billion yuan and 5 1.003 employees. The total industrial output value, sales output value, added value, profit and tax are1426 million yuan,1359 million yuan, 4.57 billion yuan, 2,065.438+0 billion yuan and 2.69 billion yuan respectively. The fixed assets, employees, total industrial output value, sales output value, added value and profit of pharmaceutical manufacturing industry accounted for 14.2%,1/0.9%,110.5% and12, respectively.
Problems existing in Shijiazhuang pharmaceutical chain enterprises;
However, in the investigation, it was also found that there were many unsatisfactory situations in Shijiazhuang pharmaceutical chain enterprises.
There are many problems, such as weak awareness of intellectual property protection in enterprises, insufficient technological innovation in pharmaceutical enterprises, small number of patent applications, low level, close relationship between patents and R&D, low overall quality of patent talents in enterprises, and low level of patent information utilization.
How to solve the existing problems:
1: Optimize enterprise innovation mechanism and promote the quality of enterprise patent creation. Enterprises should strengthen market-oriented, enterprise-oriented and integrated medical research technology, enhance market competition consciousness, optimize innovation mechanism, improve enterprise's scientific and technological research and development ability, and realize the coordinated development of science and technology and patents.
2. Enhance the awareness of property rights strategy in the process of implementing enterprise knowledge strategy, and accelerate the implementation of patent strategy of pharmaceutical enterprises. We must take the concept innovation as the guide, strengthen the intellectual property awareness of enterprises, and truly realize the importance, urgency and market compulsion of pharmaceutical enterprises to implement patent strategy. In promoting the patent of pharmaceutical enterprises, it is necessary to strengthen classified guidance, focus on breakthroughs, and cooperate and interact. It is necessary to combine technical experts, economic analysis experts and legal experts, with technological innovation as the means, conceptual innovation as the premise, mechanism innovation as the driving force and environmental innovation as the guarantee. Take? Market orientation, industrial agglomeration, enterprise interaction? The virtual fleet propulsion mode is the main feature.
3. Give full play to the role of government functions and strive to create a market environment that encourages innovation. Give play to the leverage of government funds, support and encourage enterprises to increase investment in technological innovation, and guide enterprises to gradually increase the proportion of R&D investment. Focus on cultivating enterprises with intellectual property advantages, and do a good job in patent innovation demonstration enterprises and patent technology to participate in the pilot work. Science and technology departments should strengthen the guidance of intellectual property rights and improve the quantity and quality of patents obtained by government scientific and technological innovation achievements. The municipal government and relevant departments should provide a strong guarantee for the implementation and promotion of technological innovation in the pharmaceutical industry as soon as possible.
2 1 century will be an era of great change and development of China's circulation industry. Developing franchise chain operation is an urgent and important task. In order to make the franchise chain enter the fast lane of development as soon as possible, the following work needs to be done:
1: Actively cultivate professionals in chain enterprises. Chain is the license of commercial intellectual property rights, which involves many fields such as commerce, industry, science and technology, law, management, and sometimes even agriculture. Chain professionals are urgently needed.
2. Accelerate the standardization of chain operation and systematic manual construction, and improve the degree of operation organization. The key to the development of chain science lies in the establishment of efficient business flow and logistics system, the implementation of standardized management and services, especially the formation of standardized management within franchised enterprises, which is the basis of chain development. Without standardization, there can be no real chain operation, and there can be no scale advantage and scale benefit. Therefore, franchise chain enterprises should adhere to standardized management in expanding organizational scale, developing franchise stores and carrying out daily business activities, regardless of decision-making, management or general business operators.
In a word: Shijiazhuang pharmaceutical chain enterprises have a good development prospect.
;